home  |  contact  |  worldwide sites  |  novartis.com
News and Events

Current news

Archives
 
News

 

January 21, 2008

 

Back to all media releases

 

Novartis Bangladesh Debate Competition

 

 

Dhaka, January 21, 2008 - Novartis Bangladesh Debate Competition comes to a successful end.

Six debaters from two teams came together in front of more than 900 Associates to debate about "Cable Television should be censored for the betterment of the society", a prominent topic of conversation amongst the general population in the Bangladesh society today.

The idea of the debate competition originated towards early September 2007, when the Diversity and Inclusion Team proposed to organize a programme for Sales and Distribution colleagues, because normally they do not get the opportunities to showcase their aptitudes.

84 candidates were nominated in the preliminary round, where Associates from all over Bangladesh debated on selected topics. For the secondary round, the participants were screened and 24 Associates were selected from whom the last 6 participant were screened and selected after a third round.T he intense interaction, research and grooming improved the internal thinking capacity of these sales colleagues and created champions of Diversity and Inclusion within the Company.

The judges of the event were from the fields of academics and media, Dr. Ferhat Anwar and Asaduzzaman Noor. Both are leading experts on society, culture and media. Along with the external judges was also Mr. Tauheen Hossain, the Head of Animal Health Business Unit as the third judge of the competition.

The outcomes of the day mainly were team building, making others think from a different perspective and also entertainment.

 

 

 

 

About Novartis  

Novartis is a world leader in offering medicines to protect health, treat diseases and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. Novartis is the only company with leadership positions in both patented and generic pharmaceuticals (Sandoz). We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high quality and affordable generics (Sandoz), human vaccines and leading self-medication OTC brands. Headquartered in Basel, Switzerland, Novartis Group companies employ more than 100,000 people and operate in over 140 countries around the world.

Novartis has manufacturing and marketing operations in Bangladesh since 1973 in areas of Research, Off Patent Branded Generic (Sandoz) and OTC Pharmaceuticals along with Animal Health.

 

 

 

###

 

    

Novartis (Bangladesh) Limited Media Relations

 

Rasna Hasan

Head of Corporate Affairs and Communication

Novartis (Bangladesh) limited

House 50, Road 2A

Dhanmondi RA

Dhaka 1209

BANGLADESH

 

+880 2 8615302-8

 rasna.hasan@sandoz.com

 

The information in the media releases on these pages was factually accurate on the date of publication. These media releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

 

 
 
 

 

Download

 

 Product Launch

Lucentis

Aclasta

Sebivo

Ticlon

Doloran PRT

 35 Years in the Bangladesh

 
 
Use of this website is governed by our Terms of Use and Privacy Policy © 2008 Novartis (Bangladesh) Limited